Boston Scientific (BSX) Shareholder's Equity Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 333.76% |
| Sep 30, 2025 | 8.71% |
| Jun 30, 2025 | -44.38% |
| Mar 31, 2025 | 72.04% |
| Dec 31, 2024 | 140.60% |
| Sep 30, 2024 | 39.87% |
| Jun 30, 2024 | 15.91% |
| Mar 31, 2024 | 65.06% |
| Dec 31, 2023 | 2.40% |
| Sep 30, 2023 | 277.36% |
| Jun 30, 2023 | -5.57% |
| Dec 31, 2022 | -117.68% |
| Sep 30, 2022 | 18.38% |
| Mar 31, 2022 | 23.23% |
| Dec 31, 2021 | -5.57% |
| Sep 30, 2021 | 20.49% |
| Mar 31, 2021 | -69.52% |
| Sep 30, 2020 | 19.41% |
| Jun 30, 2020 | -54.31% |
| Mar 31, 2020 | -17.76% |
| Dec 31, 2019 | -56.18% |
| Sep 30, 2019 | -24.01% |
| Jun 30, 2019 | -17.74% |
| Mar 31, 2019 | -24.57% |
| Dec 31, 2018 | 304.59% |
| Sep 30, 2018 | -67.18% |
| Jun 30, 2018 | -17.71% |
| Mar 31, 2018 | 21.45% |
| Dec 31, 2017 | 15.04% |
| Sep 30, 2017 | 2.13% |
| Jun 30, 2017 | -1.31% |
| Mar 31, 2017 | -9.15% |
| Dec 31, 2016 | -65.57% |
| Sep 30, 2016 | -10.87% |
| Jun 30, 2016 | -11.63% |
| Mar 31, 2016 | -10.70% |
| Dec 31, 2015 | 21.81% |
| Sep 30, 2015 | -10.30% |
| Jun 30, 2015 | -9.59% |
| Mar 31, 2015 | -9.62% |
| Dec 31, 2014 | 229.85% |
| Sep 30, 2014 | -12.81% |
| Jun 30, 2014 | -13.37% |